$295 Million is the total value of Geisinger Health's 4 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 20.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AGG | Buy | ISHARES TRcore us aggbd et | $163,587,940 | -3.2% | 1,739,557 | +0.8% | 55.42% | +2.4% |
| HYG | Buy | ISHARES TRiboxx hi yd etf | $80,910,796 | -0.2% | 1,097,542 | +1.7% | 27.41% | +5.7% |
| IWB | Buy | ISHARES TRrus 1000 etf | $36,348,094 | -3.6% | 154,732 | +0.0% | 12.31% | +2.1% |
| EFV | Sell | ISHARES TReafe value etf | $14,327,438 | -17.4% | 292,815 | -17.4% | 4.85% | -12.5% |
| IEFA | Exit | ISHARES TRcore msci eafe | $0 | – | -108,797 | -100.0% | -2.35% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 4 | Q3 2023 | 55.4% |
| ISHARES TR | 4 | Q3 2023 | 27.4% |
| ISHARES TR | 4 | Q3 2023 | 20.7% |
| ISHARES TR | 4 | Q3 2023 | 6.4% |
| ISHARES TR | 3 | Q2 2023 | 15.1% |
View Geisinger Health's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-23 |
| 13F-HR | 2023-02-10 |
View Geisinger Health's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.